Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is licensed in the UK for adults aged 18 and over only. There is no upper age limit in the licence, but younger teenagers and anyone under 18 cannot legally be prescribed it for weight management, regardless of their BMI or health circumstances. Age is the first filter a prescriber applies — and it is a firm one. As a prescription-only medicine, suitability for any individual also depends on a full clinical assessment that goes well beyond age alone. If you are an adult wondering whether you qualify, the picture is a little more detailed than a single number, and it is worth understanding what else feeds into that decision.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that if a teenager is clinically obese, weight-loss medicines should be on the table. That is understandable, obesity can cause serious harm at any age. Mounjaro simply has not been studied in people under 18 in the context of weight management, so the MHRA has not licensed it for that group. Prescribing an unlicensed medicine to a minor is a different legal and clinical matter entirely, and no reputable UK pharmacy or prescriber will do it routinely.
The same restriction applies to Wegovy (semaglutide injection) and the newly approved oral weight-loss medicines now available in the UK. Young people struggling with their weight need a different pathway (typically through paediatric or specialist services) and their GP is the right starting point. It is not a gap that a private online prescription fills.
For adults who have just turned 18, the good news is that the licence does not carry a grace period or a minimum time at that age. If you are 18 and meet the clinical criteria, age is no longer the barrier.
Once age is cleared, prescribing decisions rest on BMI and health history. The Mounjaro licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition, things like high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. If you want to understand what weight you need to be for Mounjaro, it is worth knowing that UK guidance applies thresholds 2.5 kg/m² lower for certain ethnic backgrounds, reflecting differences in health risk at a given BMI.
A prescriber also looks at what is not on the criteria list: a history of pancreatitis, certain thyroid conditions (medullary thyroid carcinoma or a genetic condition called MEN2), pregnancy, breastfeeding or actively trying to conceive all mean Mounjaro is not appropriate. Being on an oral contraceptive pill raises a practical point rather than an exclusion, the NHS advises adding a non-oral method of contraception for the first four weeks of treatment and after each dose increase, because tirzepatide can slow stomach emptying in a way that may affect how the pill is absorbed. Worth knowing before you start.
If you want to understand how approval decisions are made in practice, this page on getting approved for Mounjaro walks through the process step by step.
The Mounjaro licence does not set an upper age boundary. Adults in their 60s, 70s and beyond have been included in the clinical programme, and NICE's appraisal of tirzepatide (published as NICE technology appraisal TA1026) does not apply an age ceiling to its recommendations. In practice, a prescriber will take a more careful look at someone's full health picture as they get older: kidney function, cardiovascular history, other medicines, and whether the expected benefit outweighs any individual risk. That is not a barrier so much as good medicine.
Side effects are the same across adult age groups in broad terms, the most common are gastrointestinal (nausea, loose stools, reflux, reduced appetite) and tend to be most noticeable in the early weeks of treatment. Older adults, particularly those on multiple medicines, may find it worth discussing any new symptoms promptly with their prescriber or GP. The NHS tirzepatide page sets out the full side-effect profile clearly.
If you are curious about newer medicines currently in trials that may eventually reach the UK market for weight management, comparisons such as retatrutide versus Mounjaro give a sense of where research is heading, though none of those options are yet available for prescription.
If you are 18 or over and think you may qualify on clinical grounds, the next practical step is a formal consultation. At nume, that means completing a clinical questionnaire which is read the same day by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. Identity and current weight are verified directly. If treatment is clinically suitable and you order before noon on a working day, your prescription is dispatched the same day and arrives free via DPD the following working day, in plain packaging.
It is worth being clear-eyed about cost at this stage. Private Mounjaro treatment is not cheap, and if budget is a consideration, the context around Mounjaro pricing in the UK is useful reading before you commit. Eli Lilly adjusted list prices significantly in late 2025, and typical private costs now vary meaningfully by dose and provider. At nume, one price covers the consultation, prescription, treatment and delivery, no subscription, no hidden charges.
Thinking about how to get the best start once a prescription is in place? Preparing for Mounjaro covers the practical side: what to have ready, what to expect in the first few weeks, and small habits that make a real difference. When you are ready to take that first step, check your eligibility with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.